Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
about
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyUrokinase receptor and resistance to targeted anticancer agentsThe role of saliva in tick feedingAdaptive evolution of formyl peptide receptors in mammalsLarge-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases.Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.Activation of basophils is a new and sensitive marker of biocompatibility in hemodialysis.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonistsUrokinase and its receptors in chronic kidney disease.Structural basis of interaction between urokinase-type plasminogen activator and its receptorSynthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonistsThe 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity.Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec.Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.The inflammatory actions of coagulant and fibrinolytic proteases in disease.Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.HIV-1 Nef promotes migration and chemokine synthesis of human basophils and mast cells through the interaction with CXCR4.The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis.Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87).Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune FunctionsThe Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF ReceptorsRegulation of melanocortin 1 receptor in allergic rhinitis in vitro and in vivo.N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor.
P2860
Q24652940-A642DBFA-2DF6-4623-9CE2-B7D57B9AF813Q26797385-CA1DF835-5825-4C36-9464-C1CB32C51ADAQ27490448-E2221F38-3706-4ACD-A2B0-1D9586622D83Q28256027-345B6AAF-28EE-4691-8997-DF4DB68C95F7Q30276495-C200F775-C427-44C1-B1EA-ACADB2508721Q33709060-E5505DC6-73E7-48D4-B9A5-5E736EE731A4Q33749766-475F4D25-93FE-41CC-916A-63B0E1A0FCD4Q34089936-8BF97443-3617-49E7-92CF-7F254C3E43EDQ34100895-79325B1B-5BBE-476E-862C-9B04221DED1DQ34637690-291372B5-5524-43A8-B38C-59021857FEF6Q34645842-18F35433-8358-4591-A775-A454C1C2B951Q35124141-BE9C9D76-1753-4893-AA41-9D647973FCBEQ36237711-56A8FC9F-AF0F-4455-82CD-E6F55AE630E8Q36590244-A64C5877-1D82-4CC4-86D2-2AB614944F06Q36604431-37F65C6D-822C-457F-8DCF-E0AB1C277BD5Q37011702-22291C14-D6EF-4642-9624-B10CD9B4B6F9Q37187551-3C1CAA82-691A-4F90-A94D-0052E780B99FQ37432551-C5B36DF6-D6AE-46E4-B653-5911F1462E81Q38162151-731DCD0E-4758-4460-B3CC-8235E8413A90Q38423064-86DF1A3B-17DA-4811-A4C4-F6EA0E432EFCQ38583085-5F944FB5-B7CB-443F-9731-7E8F0079CC3EQ38952582-C30D5149-E005-41AE-88F8-51EBE3D09B5BQ39196591-3C47B8CF-5E37-41A1-871E-36EA2BB20041Q39206825-2DBF80D4-696D-4F85-8355-DB2E9DF732C9Q39640346-DB1D6EF2-80C2-4018-B07F-EF2BD5784AEDQ39799154-9D7CAE0A-EDE4-499C-BFA2-D0142BFED41FQ39933331-A04E9F6B-8248-4468-B3C3-316F6935FB4AQ41518094-0EDF9948-1173-45E2-8D33-27C98E623421Q42335943-5A3A64C3-011F-4C49-B046-9CA3FC903A84Q42364244-2A3B7B2D-5241-4A89-8ED9-D4B1093DBA68Q51521838-F1F316A2-F2A1-4AC4-AE0F-75367C61C981Q52718407-47093FE1-4F3A-4F6E-A4B3-A725129721E0
P2860
Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Urokinase induces basophil che ...... e receptor-like 1 and -like 2.
@en
type
label
Urokinase induces basophil che ...... e receptor-like 1 and -like 2.
@en
prefLabel
Urokinase induces basophil che ...... e receptor-like 1 and -like 2.
@en
P2093
P1476
Urokinase induces basophil che ...... e receptor-like 1 and -like 2.
@en
P2093
Amato de Paulis
Francesca Wanda Rossi
Gianni Marone
Guido Rossi
Isabella Fiorentino
Nella Prevete
Nunzia Montuori
Valeria Visconte
P304
P356
10.4049/JIMMUNOL.173.9.5739
P407
P577
2004-11-01T00:00:00Z